Related Experiment Video
Updated: Feb 6, 2026
Paramagnetic Relaxation Enhancement for Detecting and Characterizing Self-Associations of Intrinsically Disordered Proteins
Published on: September 23, 2021
Tailored psychotherapy and AI-enhanced contingency management for co-occurring disorders in cannabis use disorder: a
Sidharth Mishra1, Sayali Mishra1, Sibanarayan Rath2
1Department of Psychiatry, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.
Background:
Cannabis use disorder (CUD) commonly co-occurs with depression, post-traumatic stress disorder (PTSD), anxiety, and attention-deficit/hyperactivity disorder (ADHD), resulting in poorer outcomes and underscoring the need for tailored interventions. Contingency management (CM) is one of the most effective behavioral treatments for substance use disorders, and emerging applications of artificial intelligence (AI) may enhance CM by predicting relapse risk and personalizing incentives. This review evaluates evidence on integrated interventions for CUD with co-occurring disorders and the developing role of AI-enhanced CM.
Methods:
A systematic search of PubMed, PsycINFO, Embase, and Web of Science (through October 2025) identified clinical studies and systematic reviews on tailored interventions for CUD with depression, PTSD, anxiety, or ADHD, as well as research on AI-driven CM. Data were extracted on study design, interventions, and outcomes.
Results:
Thirty-eight studies met inclusion criteria. Integrated cognitive-behavioral therapies improved psychiatric symptoms and reduced cannabis use, particularly in depression and PTSD. Pharmacotherapies showed inconsistent benefits, while ADHD-focused behavioral and stimulant-based approaches demonstrated promising reductions in cannabis use. AI applications such as machine-learning prediction of relapse using smartphone/sensor data, remote CM delivery, and reinforcement-learning-based incentive optimization-improved attendance, abstinence verification, and reward efficiency.
Conclusion:
Integrated psychosocial approaches and AI-augmented CM offer complementary pathways for improving outcomes in individuals with CUD and co-occurring disorders. Combining personalized psychotherapy with adaptive, technology-assisted reinforcement may strengthen treatment efficacy.
Related Concept Videos
02:18Intrinsically Disordered Proteins
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
01:30Other Disorders of Digestive System
01:27Panic Disorder